Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV study of Benvitimod cream in adults with mild-to-moderate psoriasis
ChiCTR2100050043Phase 4Not yet recruiting
- Sponsor
- Peking University People's Hospital
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tapinarof in plaque psoriasis, sponsored by Peking University People's Hospital. Primary endpoints: Psoriasis lesion area and severity index (PSAI), Physician Global Assessment (PGA) and 1 more. Planned start May 2021; status: not yet recruiting.
02
Drugs
tapinarof
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on ChiCTR2100050043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050043.